این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Addiction and Health، جلد ۱۵، شماره ۴، صفحات ۲۴۰-۲۴۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Methadone Dose and Timing of Administration as Predictors of Sleep Apnea Syndrome During Methadone Maintenance Treatment: A Retrospective Cross-sectional Study
چکیده انگلیسی مقاله Background: This study aimed to assess the association of sleep apnea syndrome (SAS) with methadone dose and timing of 
administration in patients receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD).
Methods: This retrospective cross-sectional study was conducted on adult patients receiving MMT who had a nocturnal 
respiratory polygraphy between November 2015 and December 2021. Data on methadone treatment and polygraph recording, 
including the apnea-hypopnea index (AHI) were collected.
Findings: A total of 40 patients, mostly male (72.5%), with a mean age of 35±6.7 years and a mean body mass index (BMI) of 
25.1±4.5 kg/m² were included. The daily dose of methadone was significantly associated with an AHI≥15 events/h as well as 
an AHI≥30 events/h, even after adjustment for age, gender, BMI, and benzodiazepine use. However, these associations were not 
preserved when the time of administration (day vs evening) was considered, while the evening administration was significantly 
associated with an AHI≥15 events/h. The best sensitivity and specificity for the prediction of AHI≥15 events/h and AHI≥30 
events/h were obtained with daily methadone doses of≥72.5 mg and 77.5 mg, respectively.
Conclusion: In this sample of MMT patients, methadone doses of 72.5 mg and 77.5 mg were the best cut-off values for predicting 
AHI≥15 and≥30 events/h, respectively, especially when taken in the evening. These results should draw clinicians’ attention to 
the importance of SAS screening, and further studies are needed, notably comparisons with buprenorphine. 
کلیدواژه‌های انگلیسی مقاله Opioid-related disorders, Methadone, Sleep apnea syndrome
نویسندگان مقاله Clément Guillet |
1. Sleep Exploration Centre, La Chartreuse Psychiatric Hospital, 21000 Dijon, France 2. Depression Unit, La Chartreuse Psychiatric Hospital, 21000 Dijon, France

Francky Teddy Endomba |
1. Medical Mind Association, Yaoundé, Cameroon 2. Sleep Specialized Transversal Training, Psychiatry Internship Program, University of Burgundy, 21000 Dijon, France

David Aravantinos |
1. Sleep Exploration Centre, La Chartreuse Psychiatric Hospital, 21000 Dijon, France 2. Addictology Unit, La Chartreuse Psychiatric Hospital, 21000 Dijon, France

Aymard Hussami |
Sleep Exploration Centre, La Chartreuse Psychiatric Hospital, 21000 Dijon, France

Florence Beye |
Pharmacy Unit, La Chartreuse Psychiatric Hospital, 21000 Dijon, France

Jean Claude Girod |
Sleep Exploration Centre, La Chartreuse Psychiatric Hospital, 21000 Dijon, France

Ludwig Serge Aho Glélé |
Service D’épidémiologie Et D’hygiène Hospitalière, CHU Hôpital D’enfants, 14 Rue Paul 10 Gaffarel, 21079, Dijon, France

نشانی اینترنتی https://ahj.kmu.ac.ir/article_92381_f1006f72e9d99cf62320c3e6c96af0a1.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات